BIONTECH SE-ADR (BNTX:NASDAQ)
$111.6 6.41 (6.0937%)
Analysed BIONTECH SE-ADR (BNTX:NASDAQ) News Sources
BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026
21-04-2026
yahoo.com
Pfizer's Non-Oncology Portfolio in Focus Ahead of Q1 Earnings
15-04-2026
yahoo.com
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer
11-04-2026
yahoo.com
How The BioNTech (BNTX) Story Is Shifting With New Leadership And Post COVID Pipeline Bets
08-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading
07-04-2026
yahoo.com
BMO Capital Cuts PT on BioNTech SE (BNTX) to $128 From $143 – Here’s Why
31-03-2026
yahoo.com
3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next
30-03-2026
247wallst.com
BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer
24-03-2026
yahoo.com
BioNTech Cofounder Exits Put Leadership Transition And Pipeline Execution In Focus
22-03-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading
19-03-2026
yahoo.com
What is the current price of BIONTECH SE-ADR (BNTX:NASDAQ)?
The current price of BIONTECH SE-ADR (BNTX:NASDAQ) is $111.6.
BIONTECH SE-ADR (BNTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIONTECH SE-ADR (BNTX:NASDAQ) since the previous trading day is $6.41.
BIONTECH SE-ADR (BNTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIONTECH SE-ADR (BNTX:NASDAQ) since the previous trading day is 6.0937%.
What is the most recent average sentiment score for BIONTECH SE-ADR (BNTX:NASDAQ)?
The most recent average sentiment score for BIONTECH SE-ADR (BNTX:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for BIONTECH SE-ADR (BNTX:NASDAQ)?
The most recent sentiment for BIONTECH SE-ADR (BNTX:NASDAQ) is .
SEC-8K** Filing Available For BIONTECH SE-ADR (BNTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.